“…Both, ABE and SABE have been successfully used to analyze dOFM data (Bodenlenz et al, 2017;Tiffner et al, 2020) Strengths of dOFM for PK-based BE studies dOFM can be used to sample any API regardless of its molecular size or structure or the formulation that is used for its delivery. dOFM has already been successfully used to sample lipophilic (Bodenlenz et al, 2012;Holmgaard et al, 2012;Bodenlenz et al, 2016), high-molecular-weight (Dragatin et al, 2016;Kolbinger et al, 2017) and hydrophilic APIs with low skin permeation ability (Bodenlenz et al, 2017), bound and unbound drugs, peptides, proteins, antibodies, and APIs with high-protein-binding properties (Dragatin et al, 2016;Kolbinger et al, 2017;Hummer et al, 2020;Tiffner et al, 2020). dOFM samples reflect the molecular composition of the ISF because sampling collects diluted but unfiltered dermal ISF.…”